Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

About Regenerative Medicine

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE...

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

Contact Regenerative Medicine

Web
http://www.future-science-group.com/journalprofile/regenerative-medicine/

Intro Content

Introducing the new Regenerative Medicine aims and scope

Introducing the new Regenerative Medicine aims and scope

​In light of the 10-year anniversary of the award-winning journal …

Go to the profile of Matt Hall

Matt Hall

Creative Director, Zapnito

Go to the profile of Phil Garner

Phil Garner

Managing Director, Future Science Group, FSG

Go to the profile of James Amissah

James Amissah

RegMedNet - Digital Project Manager, FSG

Go to the profile of Laura Dormer

Laura Dormer

Editorial Director, Future Science Group

Go to the profile of Alexandra Thompson

Alexandra Thompson

Contributor, -

Go to the profile of Leela Ripton

Leela Ripton

Head of Marketing, Future Science Group

Go to the profile of Dionne Murray

Dionne Murray

Business Development Manager, Future Science Group

Go to the profile of Chris Mason

Chris Mason

Professor, -

Go to the profile of Alan Regenberg

Alan Regenberg

Director of Outreach and Research Support, Johns Hopkins Berman Institute of Bioethics, -

Go to the profile of Norio Nakatsuji

Norio Nakatsuji

Professor, iCeMS/Inst Front Med Sci, Kyoto Univ. and Advisor, Kyoto Stem Cell Innovation, Inc., -

Go to the profile of Elena Conroy

Elena Conroy

Contributor, Future Science Group

Go to the profile of Susan L. Solomon

Susan L. Solomon

CEO and Co-Founder-, The New York Stem Cell Foundation Research Institute

Go to the profile of Paul Kemp

Paul Kemp

CEO and CSO, Intercytex Ltd

Go to the profile of Dusko ILIC

Dusko ILIC

Reader in Stem Cell Science, King's College London

Go to the profile of Timothy Caulfield

Timothy Caulfield

Professor, University of Alberta

Go to the profile of Michael H. May

Michael H. May

-President & CEO, -CCRM

Go to the profile of Giulia Gigliobianco

Giulia Gigliobianco

PhD Student in Tissue Engineering and Regenerative Medicine at University of Sheffield, Kaplan Higher Education

Go to the profile of Dr Reaz Vawda

Dr Reaz Vawda

Senior Post-Doc. #Brain, #Retinal & #SpinalCordInjury/ Neuro(D/R)egeneration; #StemCell Therapy & #RegenerativeMedicine, Krembil Neuroscience Centre, Toronto Western Research Institute, University Health Network

Go to the profile of kwang sik, kook

kwang sik, kook

C E O, Idea plastic surgery

Go to the profile of Francisco dos Santos

Francisco dos Santos

Founder and CSO at Cell2B, Cell2B Advanced Therapeutics SA

Go to the profile of Ryan Chang

Ryan Chang

President of Steminent Biotherapeutics, Steminent Biotherapeutics